US$ 24.54
do glp-1 agonists have cardiovascular benefit Frontiers Glucagon-like peptide 1 receptor agonists:
Description
3 These adverse effects occur due to delayed gastric emptying, which prolongs satiety but can lead to discomfort

Note: animal studies indicate that high doses of DPP-4 inhibitors & GLP-1 agonists cause expansion of cells of the pancreatic ductal glands and can cause premalignant pancreatic intraepithelial lesions (PanIN) that have the potential to progress to pancreatic adenocarcinoma

10.1007/s10735-010-9304-4 43 KassemS.KhalailaB.SteinN.SalibaW.ZainaA

Abdelmalek, J
May 30, 2025
